These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30800174)

  • 1. Current advances in the treatment of giant cell arteritis: the role of biologics.
    Low C; Conway R
    Ther Adv Musculoskelet Dis; 2019; 11():1759720X19827222. PubMed ID: 30800174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of biologics in the treatment of giant cell arteritis.
    González-Gay MA; Pina T; Prieto-Peña D; Calderon-Goercke M; Blanco R; Castañeda S
    Expert Opin Biol Ther; 2019 Jan; 19(1):65-72. PubMed ID: 30513026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Giant cell arteritis: pathogenic mechanisms and new potential therapeutic targets.
    Koster MJ; Warrington KJ
    BMC Rheumatol; 2017; 1():2. PubMed ID: 30886946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic Therapies for Giant Cell Arteritis.
    Harrington R; Al Nokhatha SA; Conway R
    Biologics; 2021; 15():17-29. PubMed ID: 33442231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of giant cell arteritis.
    González-Gay MÁ; Pina T; Prieto-Peña D; Calderon-Goercke M; Gualillo O; Castañeda S
    Biochem Pharmacol; 2019 Jul; 165():230-239. PubMed ID: 31034796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giant cell arteritis: what is new in the preclinical and early clinical development pipeline?
    Harkins P; Conway R
    Expert Opin Investig Drugs; 2022 Sep; 31(9):921-932. PubMed ID: 34106030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic Therapy for the Treatment of Giant Cell Arteritis.
    Ostrowski RA; Bussey MR; Tehrani R; Jay W
    Neuroophthalmology; 2014; 38(3):107-112. PubMed ID: 27928284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and emerging diagnosis tools and therapeutics for giant cell arteritis.
    González-Gay MA; Pina T; Prieto-Peña D; Calderon-Goercke M; Blanco R; Castañeda S
    Expert Rev Clin Immunol; 2018 Jul; 14(7):593-605. PubMed ID: 29877748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological treatments in giant cell arteritis & Takayasu arteritis.
    Samson M; Espígol-Frigolé G; Terrades-García N; Prieto-González S; Corbera-Bellalta M; Alba-Rovira R; Hernández-Rodríguez J; Audia S; Bonnotte B; Cid MC
    Eur J Intern Med; 2018 Apr; 50():12-19. PubMed ID: 29146018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing treatment options for large vessel vasculitis.
    Macaluso F; Marvisi C; Castrignanò P; Pipitone N; Salvarani C
    Expert Rev Clin Immunol; 2022 Aug; 18(8):793-805. PubMed ID: 35714219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the clinical management of giant cell arteritis and Takayasu arteritis.
    Koster MJ; Matteson EL; Warrington KJ
    Curr Opin Rheumatol; 2016 May; 28(3):211-7. PubMed ID: 26885650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of polymyalgia rheumatica and large vessel vasculitis].
    Hellmich B
    Internist (Berl); 2016 Nov; 57(11):1069-1078. PubMed ID: 27631531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
    Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the management of giant cell arteritis.
    Roberts J; Clifford A
    Ther Adv Chronic Dis; 2017 Apr; 8(4-5):69-79. PubMed ID: 28491267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of large-vessel vasculitis.
    Salvarani C; Hatemi G
    Curr Opin Rheumatol; 2019 Jan; 31(1):25-31. PubMed ID: 30461542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the Treatment of Giant Cell Arteritis.
    Castañeda S; Prieto-Peña D; Vicente-Rabaneda EF; Triguero-Martínez A; Roy-Vallejo E; Atienza-Mateo B; Blanco R; González-Gay MA
    J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Giant Cell Arteritis (GCA).
    Régent A; Mouthon L
    J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in Giant Cell Arteritis.
    Guevara M; Kollipara CS
    Curr Rheumatol Rep; 2018 Apr; 20(5):25. PubMed ID: 29611005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Giant Cell Arteritis and Takayasu Arteritis-Current and Future.
    Hellmich B; Águeda AF; Monti S; Luqmani R
    Curr Rheumatol Rep; 2020 Oct; 22(12):84. PubMed ID: 33044642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the treatment of giant cell arteritis.
    Springer JM; Kermani TA
    Best Pract Res Clin Rheumatol; 2023 Mar; 37(1):101830. PubMed ID: 37328409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.